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A method for the determination of clenbuterol (CLB) concentration in bovine liver by
reversed-phase high-performance liquid chromatography (HPLC) with UV detection was
developed. The sample was extracted with acetonitrile and isopropanol, followed by HPLC
analysis. A reverse-phase column C18 was used, with a UV detector at 214 nm and 0.05 M
NaH2PO4 (pH 3.0)/acetonitrile (85:15, v/v) as the mobile phase. The accuracy of the
analytical method was estimated by spiking bovine liver samples with three different
concentrations of CLB (5.24 ng/g, 20.98 ng/g, and 41.96 ng/g) and recovery of 111.7%, 82.0%,
and 84.8%, respectively, was obtained. The precision of the method was estimated by the
relative standard deviation, which was < 4.74%. The limit of detection and quantification of
CLB were 0.20 ng/g and 0.42 ng/g of liver sample, respectively, and the retention time was
24.82 minutes. The recent discovery of CLB contamination in Mexican food led to the
specific inspection of a distribution center for this b-agonist, involving the analysis of a
total of 78 bovine liver samples. Of all samples screened, 62% of them had concentrations
above the maximum residue limit of 0.6 ng/g set by the United Nations Food and Agri-
cultural Organization for CLB. The analytical method was found to be rapid, sensitive,
accurate, repeatable, and reproducible, and could be applied to the measurement of CLB
concentration in bovine liver.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
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tioning agent inmeat-producing animals [4e6]. The use of CLB
as a growth promoter in cattle destined for human con-
sumption is illegal and implies a threat to public health,
because several human poisonings have been linked to the
consumption of meat products contaminated with CLB resi-
dues [7]. The use of CLB as a growth promoter in cattle is
banned in the European Union [8], Mexico [9e11], and many
other countries. The human effects include increased heart
rate and blood pressure, anxiety, palpitation, and tremor in
skeletal muscle [12]. The Codex Alimentarius Commission
recommends maximum residue limits (MRLs) for cattle of
0.2 ng/g in muscle and fat, 0.6 ng/g in liver and kidney, and
0.05 ng/mL for cattle milk, expressed as parent drug [13].
To analyze residues in animal tissues, it should be noted
that they are highly complex feature matrices; furthermore,
the extraction and detection of substances present in con-
centrations of the order of ng/g (ppb), or even less, should be
performed with high selectivity [14]. For food security, the
analytical method for determining residues of CLB is indis-
pensable. There are various methods for determining CLB,
including immunological techniques such as enzyme-linked
immunosorbent assay [14,15], gas chromatography coupled
with mass spectrometry (GC/MS) [16e18], high-performance
liquid chromatography (HPLC)eUV detection [5,19,20], and
liquid chromatography coupled with tandem mass spec-
trometry (LC/MS/MS) [21] or with mass spectrometry (LC/MS)
[22] . Of the reported methods, immunological techniques are
the least used for quantification, although they are fast qual-
itative screening techniques. GC/MS methods involve tedious
steps for derivatization of CLB [23]. Thus, HPLC was chosen as
the technique for fast and accurate quantification of CLB in
bovine liver samples.
In the present work, a rapid, accurate, and sensitive
method for determining CLB by HPLC with UV absorbance
detection was optimized with reference to published pro-
cedures of the United States Department of Agriculture
(USDA) [12] and Chang et al [5]. A simple and time-saving
method for extraction and filtration for direct analysis was
used in this experiment. The main objective of this study was
to develop the optimal conditions for the HPLCmethod, which
could be applied to the determination of CLB in bovine liver.
This analytical method was then implemented to determine
the CLB levels in samples purchased from a meat distribution
center in Mexico City.2. Methods
2.1. Reagents
Standard clenbuterol hydrochloride (95%)was obtained from
SigmaeAldrich (St Louis, MO, USA). Acetonitrile (J.T. Baker,
Phillipsburg, NJ, USA) and isopropanol (Burdick & Jackson,
Muskegon, MI, USA) were of HPLC grade. The other chemicals
and solvents, such as sodium chloride, sodium sulfate, mag-
nesium sulfate, and sodium dihydrogen phosphate, were of
analytical-reagent grade and purchased from J. T. Baker (Eca-
tepec, Mexico). All aqueous solutions were prepared using
Type I ultrapure water (Purelab Flex, Elga LabWater, UK).2.2. Preparation of stock and standard solutions of CLB
The stock solution of clenbuterol hydrochloride was prepared
by dissolving an appropriate amount of the drug in ultrapure
water to obtain a concentration of w1 mg/mL and stored in
the dark at 4C for no longer than 2 months. The clenbuterol
hydrochloride concentration was corrected for salt and purity
[12] because CLB is the analyte of interest as opposed to
clenbuterol hydrochloride, therefore, the real concentration in
the stock solution was 839.56 mg/mL. Working standard solu-
tions were prepared each day by gradual dilution with the
mobile phase. Standard curves were plotted using peak areas
versus known concentrations.2.3. Equipment
The HPLC system was a Hitachi Elite LaChrom chromatogra-
pher (Tokyo, Japan) equipped with an L-2420 UV-Vis detector,
an L-2300 column oven, an L-2200 autosampler, and an L-2130
pump. EZChrom Elite 3.3.2 SP2 software (Agilent Technolo-
gies, CA, USA) was used for data acquisition.
2.4. Chromatographic conditions
Chromatographic separation was executed in a Restek Ultra
C18 analytical column (250 mm  4.6 mm, internal diameter,
5 mm; Bellefonte, PA, USA). The mobile phase was 50 mM
NaH2PO4 (adjusted to pH 3.0 with orthophosphoric acid/
acetonitrile; 85:15, v/v) and its flow rate was set at 1.0 mL/min.
Prior to use the mobile phase was filtered through a Millipore
0.45-mm filter (EMD Millipore Corporation, MA, USA). The
detection wavelength of the detector was set at 214 nm. The
column temperature was maintained at 25C.
2.5. Bovine liver
A total of 78 bovine liver samples were collected from a meat
distribution center in Mexico City on five different dates dur-
ing July 2012 to November 2012. Each sampling collected
13e17 samples, which weighed w250 g. Samples were kept
frozen at 20C until analysis.
2.6. Extraction
For sample extraction, 5.0  0.1 g of homogenized liver was
weighed, and 4 mL acetonitrile and 2 mL isopropanol were
added, and then the mixture was ground for 30 seconds. The
mixture was placed into a 50-mL centrifuge tube and 1.2 g
NaCl was added and vortexed for 2 minutes, then 4 g Na2SO4
and 0.5 g MgSO4 were added and vortexed for 2 minutes. The
samples were centrifuged for 15 minutes at 2000g. The total
extract was transferred into a 50-mL round-bottom flask and
rotoevaporated to dryness. The residue was dissolved in
1.0mL ofmobile phase, vortexed for 2minutes, sonicated for 2
minutes, and filtered using a 3-mL syringe and 0.45-mm nylon
filter into a vial. Fifty microliters of this solution was injected
into the HPLC column. Peak identification was made by
comparing the retention times of samples with those of the
standard solutions.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 4 1 4e4 2 0416Spiked tissues were prepared by adding standard solutions
to the homogenate of control tissue prior to adding salts, fol-
lowed by extraction and analysis at the same time as the
samples.2.7. Specificity of retention time for CLB
Three replicates from the same sample of liver were prepared,
which were subjected to the extraction process described
above. Two of them were fortified with CLB prior to homoge-
nization, with 2 ng/g and 25 ng/g of liver sample, whereas a
replicate was not fortified (blank).2.8. Linearity and range for standard curve of CLB
The working solutions were prepared from the stock solution
of CLB so as to contain the drug in the range of 6.5e104.9 ng/
mL. The solutions were injected in triplicate into the HPLC
column, with a constant injection volume of 50 mL and the
chromatograms were recorded. The peak area versus con-
centration datawere treated by least squares linear regression
analysis.2.9. Limit of detection and limit of quantification
The limit of detection (LOD) and limit of quantification (LOQ)
were determined according to the method based on extrapo-
lation of the calibration curve to zero concentration [24,25] by
injecting a series of spiked samples of known concentrations
near the expected limits (0.66 ng/g, 1.31 ng/g, and 1.97 ng/g) in
triplicate, and the area versus concentration datawere treated
by least squares linear regression analysis.
We used Equations 1 and 2 for the calculation of LOD and
LOQ, respectively.
LOD ¼ ðYbl þ 3SblÞ=b [1]
LOQ ¼ ðYbl þ 10SblÞ=b [2]
Where Ybl is the estimate of the blank response, Sbl is the es-
timate of the SD of the blank, and b is the slope.2.10. Precision of the method for determining CLB
Precision was evaluated by analyzing three replicates of three
different bovine liver samples on the same day under the
optimal conditions with the same reagents and equipment.
The mean (X) and SD were calculated for each sample
analyzed, besides the “grouped estimator” of the standard
deviation (sg) and the relative standard deviation (RSD) using
Equations 3 and 4 [24].
sg ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N k
Xk
j¼1
Xn
i¼1

Xi  Xi
2vuut (3)
RSD ¼ sg$100
X
(4)
where N is the total number of determinations, k is the
number of samples, n is the number of determinations oneach sample, Xi is the measured value in i test, and Xi is the
estimator of the population mean m.
2.11. Accuracy of the method for determining CLB
The accuracy of the assay method was evaluated in fortified
bovine liver in triplicate at three known concentration levels
of clenbuterol (5.24 ng/g, 20.98 ng/g and 41.96 ng/g). The re-
covery of the spiked drug was determined by Equation 5:
Recovery ¼ XbX$100 (5)
Where X is the mean value and X^ is the spiked value.3. Results and discussion
3.1. Extraction and chromatography
A fast, simple, and efficient extraction procedure was an
essential part of the quantification method in the present
study. The extraction procedure was a modification of that
described by USDA [12] and Chang et al [5] for the screening of
b-agonists in bovine liver by HPLC. However, in the present
study, the totality of extract was dried to increase the signal
of CLB, and the chromatographic conditions were modified.
The HPLC method was modified from previously described
methods in which a UV detector was used [20,26]. The
extraction of b-agonists from meat and other tissues has
usually been accomplished by solid-phase extraction (SPE)
using different reversed-phase adsorbents [2,4], but previous
work (data not shown) in this laboratory using SPE to separate
CLB from bovine liver indicated that it resulted in low
extraction efficiency.
Several HPLC methods that have been published for the
extraction and determination of CLB in liver using large vol-
umes of solvents are expensive and not environmentally
friendly [2e5]. Meanwhile, compared with GC methods that
are generally used for the determination of b-adrenergics, the
major advantages of the present method were a shorter
extraction time and the absence of a derivatization step [4].
Therefore, the procedure described here enables the direct
extraction of CLB without complementary purification steps.
Chang et al [5] reported that to avoid the tardy and tailing
peak, the optimal conditions of the mobile phase for CLB
determination were 50 mM NaH2PO4 (pH 3.0)/acetonitrile
(80:20, v/v) at 212 nm. However, in the present study, a UV
spectral scanning for CLB was tested using 50 mM NaH2PO4
(pH 3.0)/acetonitrile (85:15, v/v). The maximum UV absorp-
tion present at 214 nm was selected for CLB detection in this
study.
3.2. Specificity of retention time for CLB
The specificity test was to guarantee that CLB was reliably
determined, eliminating the possibility of false-positive re-
sults due to the presence of interference of the constituents
of the matrix used in the test or due to the decomposition-
derived elements [24,25]. In Fig. 1, representative chro-
matograms of a CLB standard, a control blank sample, and a
Fig. 1 e Chromatograms obtained from (A) a standard solution of clenbuterol (209.8 ng/mL), (B) a bovine liver (blank), and (C)
a bovine liver sample fortified with 25 ng/g of clenbuterol. High-performance liquid chromatography conditions are
described in the text.
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minutes.3.3. Linearity for standard curve of CLB
The calibration plot for the assay of CLB was linear over the
investigated range of 6.5e104.9 ng/mL, with a correlation
coefficient of 0.9997 (p < 0.05), and the equation of the line
for the best fit of the standard calibration curve was
y ¼ 1340.8563x  1539.7319 (Fig. 2).3.4. LOD and LOQ
Asociacio´n Espan˜ola de Farmace´uticos de la Industria [25]
guidelines were followed to calculate the values of LOD and
LOQ for CLB. According to values obtained in the line with
lower concentrations to the calibration curve (0.66 ng/g,
1.31 ng/g, and 1.97 ng/g), equation y¼ 1108.9xþ 119.38 and the
respective SD equation y ¼ 5.4637x þ 34.69 were obtained, of
which the corresponding values were: Ybl ¼ 119.38; Sbl ¼ 34.69;
and b ¼ 1108.9. Therefore, the LOD and LOQ values were
0.20 ng/g and 0.42 ng/g, respectively. These values were
slightly higher than those reported by Chang et al [5]
(LOD ¼ 0.1 ng/g), but below the MRL established by the
United Nations Food and Agricultural Organization for CLB.Fig. 2 e The calibration curve of clenbuterol dissolved in
mobile phase [0.05 M NaH2PO4 (pH 3.0)/CH3CN (85:15, v/v)].3.5. Precision of the method for determining CLB
The %RSD value of the grouped estimator for the precision
study was found to be 4.74%, indicating that the method was
sufficiently precise (Table 1).
Oneof the factors thatmay influence the repeatabilityof the
method of analysis is the concentration of the analyte because
the SD of the responses obtained increases with decreasing
analyte concentration. For the analysis of impurities, the As-
sociation of Official Analytical Chemists proposes several limit
values of RSD of themethod according to the concentration of
the analyte, such that when working with levels between
1000 ng/g and 100 ng/g, the acceptable RSD limits are 11% and
15%, respectively [26]. Therefore, the results obtained in the
present study (RSD ¼ 4.74%) met the specifications set.3.6. Accuracy of the method for determining CLB
The analysis of liver samples treated with CLB was similar to
that for the CLB standard, indicating that this compound was
recovered using our technique. Accuracy was determined by
spiking control bovine liver with three different concentra-
tions and treating and analyzing them as samples. The ac-
curacy was the ratio of the measured (calculated)
concentration to the added concentration. The accuracy was
111.7%, 82.0%, and 84.8% (Table 2). These values are consid-
ered acceptable because the trace analysis does not alwaysTable 1 e Results of the precision study at optimal
conditions of extraction.
Parameter Sample A Sample B Sample C Grouped
estimator
Mean 1,004,215 609,656 626,336 746,736
SD 56,308 20,273 13,579 d
sg d d d 35,431
RSD 5.6 3.3 2.2 4.74
RSD ¼ relative standard deviation; SD ¼ standard deviation.
Table 2 e Percentage recovery of bovine liver samples
artificially spiked with clenbuterol.
Amount
added (ng/g)
Value obtained
(ng/g)
Recovery (%) RSD (%)
5.24 5.9  0.5 111.7  8.6 7.7
20.98 17.2  1.0 82.0  4.8 5.8
41.96 35.6  1.0 84.8  2.5 2.9
RSD ¼ relative standard deviation.
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values between 60% and 80% [24,26]. Chang et al [5] reported
obtained average recoveries of CLB in beef of 82.6e90.6% with
a coefficient of variation of 3.57%.
High percentage recovery revealed that the proposed
methodwas accurate and could be adopted for routine quality
control analysis.3.7. Application of the method to quantification of CLB
in bovine liver
The method developed was successfully applied to the
quantification of CLB. Seventy-eight bovine liver samples
were collected from a meat distribution center in Mexico City
and treated according to the methodology described above for
the extraction of CLB and analyzed by HPLCeUV. On the
whole, 49 (62.8%) bovine liver samples contained higher levels
of CLB than the MRL set by the Codex Alimentarius Commis-
sion, which is 0.6 ng/g for liver [13]. Meat and bovine viscera
are part of the Mexican diet, thus, there have been intensified
efforts to prevent the distribution and slaughter of animals
that are fed with CLB, through the implementation and
execution of government programs in slaughter houses
[11,27]. These steps have led some livestock producers to
avoid sending animals with drug residues to markets. To
complement these actions, it is necessary to monitor period-
ically places of introduction and marketing of meat products
and to pay special attention to the collection centers of high
concentration of these products in Mexico, through the sam-
pling of meat and viscera. However, according to the results
obtained, it is a reality that illegal use of this substance during
growth remains a common practice by some producers,
especially considering that CLB accumulates in the liver inFig. 3 e Samples with residues of clenbuterol by each
sampling. CLB [ clenbuterol.large amounts (less in muscles). Therefore, the consumption
of animal viscera has a higher risk of food poisoning than
meat.
The request for meat with less fat, especially for con-
sumers in some states of Central Mexico, promotes the use of
CLB on livestock farms, so its inclusion continues. Fig. 3 shows
the trend for each batch tested monthly (Lots 1e5). The pro-
portion of samples with CLB remained constant in each
sampling, indicating consistency regarding the use of this
drug during the entire sampling period (5 months).
The use of CLB for cattle defattening is not allowed inter-
nationally. However, there have been reported cases of
human poisoning by this substance because of its presence in
bovine liver. Fig. 4 shows the levels of CLB in bovine liver
samples obtained in this investigation, and there were resi-
dues with values up to 185.3 ng/g in each sample. This was
similar to that found in Spain in 1990 by Martı´nez-Navarro
[28], which affected 135 peoplewho suffered the characteristic
symptoms of this contamination; in that case it was found
that CLB residues ranged from 160 ng/g to 291 ng/g in fresh
liver. The people were hospitalized with reversible symptoms
such as increased heart rate, muscle tremors, headache,
nausea, fever, and chills. A similar incident in France with 22
cases, also linked to bovine liver (375e500 ng/g) has been re-
ported [6,29].
Prolonged administration of a growth-promoting dose of
CLB to cattle could lead to residue accumulation in the liver as
an edible tissue, which may induce a pharmacotoxicologic
reaction in consumers. Adverse effects have been reported in
humans after ingestion of CLB at an oral dose of 10 mg/person,
four times daily. The consumption of 100 g of contaminated
liver with CLB at concentrations of 160e500 ng/g may exceed
the level of pharmacological effect [6]. The levels of CLB in
bovine liver marketed in Mexico found in the present research
(3.9e185.3 ng/g), corroborate the imminent risk that exists for
people to consume quantities that could cause severe damage
to their health.
In general, the bovine liver samples analyzed in the present
study presented with CLB concentrations lower than those
reported for cases of food poisoning in different countries:
Spain (160e291 ng/g in veal liver, 1990 [28], 19e5395 ng/g in
veal liver, 1995 [30], and 500 ng/g in veal liver, 1997 [31]); France
(375e500 ng/g in veal liver, 1991 [29]); Italy (800e7400 ng/g in
bovine meat, 1998 [32] and 1140e1480 ng/g in beef, 2000 [33]);
and Portugal (1420 ng/g in liver, 2003 and 2005) [17,34].
In Europe, Canada, and the USA, use of CLB has been
considered illegal since 1988. In Mexico, NOM-061-ZOO-1999
banned its use in the same year, but it continues to be found
in cases of human poisoning. In determining the b-agonist
in Mexico, Ortiz-Borges et al [35] reported that no CLB res-
idue was found in liver of 138 cattle slaughtered in the
municipal slaughter house of Me´rida. However, in 2008,
Estrada-Montoya et al [36] found CLB residues in beef pur-
chased from markets in Sonora, with values up to 6.12 ng/g.
Little information exists about the levels of CLB in food
poisoning cases reported in Mexico. However, work has
been done to evaluate the presence of CLB in various
matrices by enzyme-linked immunosorbent assay [37,38],
including serum of people affected by eating contaminated
meat [39].
Fig. 4 e Clenbuterol levels in bovine liver samples extracted and analyzed by high-performance liquid chromatography with
UV detection.
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CLB on livestock muscle development comes only with
pharmacological doses at least 10 times higher than the
therapeutic ones [40]. Based on the validation of this method,
it serves as an accurate and reliable method for the identifi-
cation and quantification of CLB, due to the low detection
limit, and good degrees of chromatographic separation, pre-
cision, accuracy, and sensitivity. The simplicity of this
method in the pretreatment of samples allows one to deter-
mine and quantify CLB levels in bovine liver by HPLCeUV. It
also saves reagents used as compared with other extraction
methods.
The levels of CLB found in some liver samples in our study
warn of a possible public health problem in Mexico City.4. Conclusions
In this paper, we describe a method for measuring CLB in
bovine liver. The method was precise, specific, and accurate
for this b-agonist. The recovery was reproducible (precision of
4.74%) and good (in the accepted range of 82.0e111.7%). As a
better alternative to others methods, the currently described
HPLC method determines CLB by using only a UV detector. At
lower concentrations of CLB, the extraction method produced
better results in extraction efficiency than SPE did. In view of
this, the proposedmethod could be adopted for quality control
and routine analysis. With the proposedmethod, we achieved
simple and rapid detection of CLB in bovine liver samples; part
of the animal where the largest amount of CLB is accumulated
andwhere it remains for the longest time after any treatment.
As a result of recent shocking cases of food contamination
with CLB residues in Mexico, it is important to conduct as-
sessments of the quality of meat and meat products in order
tomagnify the real problem that exists in the country with the
b-agonist.Acknowledgments
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